schizophrenia tobacco More than 50% of patients with smoke tobacco. [Fond et al 2017]; [Dickerson et al 2018]; [Oluwoye et al 2019] Despite heavily substantiated nicotine-induced metabolic and pharmacokinetic risks, this number refuses This Month in Psychopharmacology
Pay in 4 interest-free payments of $6.63 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
![schizophrenia tobacco More than 50% of patients with smoke tobacco. [Fond et al 2017]; [Dickerson et al 2018]; [Oluwoye et al 2019] Despite heavily substantiated nicotine-induced metabolic and pharmacokinetic risks, this number refuses This Month in Psychopharmacology](https://cdn.neiglobal.com/content/tmip/2024/08-30_tmip_1600x1054.png)
![schizophrenia tobacco More than 50% of patients with smoke tobacco. [Fond et al 2017]; [Dickerson et al 2018]; [Oluwoye et al 2019] Despite heavily substantiated nicotine-induced metabolic and pharmacokinetic risks, this number refuses This Month in Psychopharmacology](https://gdb.voanews.com/70ee991b-b631-450f-8b18-74430ed47bcc_w408_r1_s.jpg)
![schizophrenia tobacco More than 50% of patients with smoke tobacco. [Fond et al 2017]; [Dickerson et al 2018]; [Oluwoye et al 2019] Despite heavily substantiated nicotine-induced metabolic and pharmacokinetic risks, this number refuses This Month in Psychopharmacology](https://scx2.b-cdn.net/gfx/news/hires/2022/depressed-smoker.jpg)